AH Capital Management
Latest statistics and disclosures from a16z Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPCX, NAVN, RVMD, META, FIG, and represent 97.33% of a16z Capital Management's stock portfolio.
- Added to shares of these 4 stocks: SPCX (+$13B), RBLX (+$15M), Kailera Therapeutics, IPST.
- Started 4 new stock positions in RBLX, Kailera Therapeutics, SPCX, IPST.
- Reduced shares in these 4 stocks: FIG (-$181M), OMDA (-$25M), NAUT (-$16M), Heritage Distilling Hldg.
- Sold out of its position in Heritage Distilling Hldg.
- a16z Capital Management was a net buyer of stock by $13B.
- a16z Capital Management has $14B in assets under management (AUM), dropping by 1001.41%.
- Central Index Key (CIK): 0001540358
Tip: Access up to 7 years of quarterly data
Positions held by AH Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for a16z Capital Management
a16z Capital Management holds 19 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Space Exploration Techn Corp Class A Com Stk (SPCX) | 90.0 | $13B | NEW | 75M | 170.86 |
|
| Navan Cl A (NAVN) | 4.5 | $645M | 28M | 22.87 |
|
|
| Revolution Medicines (RVMD) | 1.2 | $173M | 921k | 187.28 |
|
|
| Meta Platforms Cl A (META) | 0.8 | $120M | 213k | 563.29 |
|
|
| Figma Class A Com Stk (FIG) | 0.8 | $108M | -62% | 6.0M | 18.09 |
|
| Bioage Labs (BIOA) | 0.6 | $79M | 3.2M | 24.51 |
|
|
| Block Cl A (XYZ) | 0.5 | $77M | 1.0M | 76.00 |
|
|
| Erasca (ERAS) | 0.4 | $52M | 2.9M | 18.32 |
|
|
| Maze Therapeatics (MAZE) | 0.4 | $51M | 1.7M | 29.84 |
|
|
| Damora Therapeutics Com New (DMRA) | 0.2 | $32M | 1.2M | 26.01 |
|
|
| Omada Health (OMDA) | 0.2 | $25M | -50% | 1.2M | 21.95 |
|
| Nautilus Biotechnology (NAUT) | 0.1 | $17M | -48% | 9.1M | 1.87 |
|
| Roblox Corp Cl A (RBLX) | 0.1 | $15M | NEW | 275k | 54.38 |
|
| Aktis Oncology (AKTS) | 0.1 | $13M | 415k | 32.23 |
|
|
| Camp4 Therapeutics Corp (CAMP) | 0.1 | $9.3M | 2.1M | 4.37 |
|
|
| Bitgo Holdings Com Shs Cl A (BTGO) | 0.0 | $3.5M | 666k | 5.18 |
|
|
| Kailera Therapeutics Common Stock | 0.0 | $3.1M | NEW | 140k | 22.03 |
|
| Ginkgo Bioworks Holdings Cl A New (DNA) | 0.0 | $1.1M | 109k | 9.91 |
|
|
| Ip Strategy Holdings (IPST) | 0.0 | $9.7k | NEW | 4.1k | 2.35 |
|
Past Filings by a16z Capital Management
SEC 13F filings are viewable for a16z Capital Management going back to 2023
- a16z Capital Management 2026 Q2 filed Aug. 14, 2026
- a16z Capital Management 2026 Q1 filed May 15, 2026
- a16z Capital Management 2025 Q4 filed Feb. 17, 2026
- a16z Capital Management 2025 Q3 filed Nov. 14, 2025
- AH Capital Management 2025 Q2 filed Aug. 14, 2025
- AH Capital Management 2025 Q1 filed May 15, 2025
- AH Capital Management 2024 Q4 filed Feb. 12, 2025
- AH Capital Management 2024 Q3 filed Nov. 13, 2024
- AH Capital Management 2024 Q2 filed Aug. 13, 2024
- AH Capital Management 2023 Q4 restated filed May 15, 2024
- AH Capital Management 2024 Q1 filed May 15, 2024
- AH Capital Management 2023 Q4 filed Feb. 14, 2024